CITIGROUP INC - WEREWOLF THERAPEUTICS INC ownership

WEREWOLF THERAPEUTICS INC's ticker is HOWL and the CUSIP is 95075A107. A total of 49 filers reported holding WEREWOLF THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.9%.

Quarter-by-quarter ownership
CITIGROUP INC ownership history of WEREWOLF THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$152
-92.4%
74
-82.7%
0.00%
Q3 2022$2,000
-33.3%
427
-42.0%
0.00%
Q2 2022$3,000
-75.0%
736
-72.6%
0.00%
Q1 2022$12,000
-87.2%
2,682
-66.1%
0.00%
Q4 2021$94,000
+526.7%
7,920
+813.5%
0.00%
Q3 2021$15,000
-57.1%
867
-57.0%
0.00%
Q2 2021$35,0002,0160.00%
Other shareholders
WEREWOLF THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
DC Funds, LP 589,102$10,274,00048.81%
MPM ASSET MANAGEMENT LLC 4,284,172$74,716,00013.89%
MPM BioImpact LLC 2,388,011$41,647,0006.84%
Soleus Capital Management, L.P. 563,396$9,826,0001.51%
RA Capital Management 4,291,881$74,850,0001.20%
SPHERA FUNDS MANAGEMENT LTD. 706,294$12,049,0000.82%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,552,787$44,521,0000.79%
Nicholas Investment Partners, LP 294,654$5,139,0000.32%
Avidity Partners Management LP 650,265$11,341,0000.31%
PFM Health Sciences, LP 400,000$6,976,0000.22%
View complete list of WEREWOLF THERAPEUTICS INC shareholders